Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
1,932
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer

Shan-Shan HongObstetrics and Gynecology Hospital, Fudan University, Shanghai, China; View further author information
,
Ming-Xing ZhangObstetrics and Gynecology Hospital, Fudan University, Shanghai, China; View further author information
,
Meng ZhangObstetrics and Gynecology Hospital, Fudan University, Shanghai, China; View further author information
,
Yi YuObstetrics and Gynecology Hospital, Fudan University, Shanghai, China; View further author information
,
Jun ChenDepartments of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China; View further author information
,
Xiao-Yan ZhangObstetrics and Gynecology Hospital, Fudan University, Shanghai, China; ;Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai, China; ;Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Cong-Jian XuObstetrics and Gynecology Hospital, Fudan University, Shanghai, China; ;Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai, China; ;Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, ChinaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-7954-5892View further author information
ORCID Icon show all
Pages 576-584 | Received 20 Dec 2017, Accepted 11 Feb 2018, Published online: 20 Feb 2018

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ming-Xing Zhang, Shan-Shan Hong, Qing-Qing Cai, Meng Zhang, Jun Chen, Xiao-Yan Zhang & Cong-Jian Xu. (2018) Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo. Drug Delivery 25:1, pages 797-806.
Read now

Articles from other publishers (18)

Nooshin Salmany, Hajie Lotfi, Rana Keyhanmanesh & Rafighe Ghiasi. (2023) An Overview of Potential Applications for Nanotechnology, Probiotics, and Medicinal Plants in Infertility Problems. Current Women s Health Reviews 19:4.
Crossref
Tengfei Zhu, Ming Kong, Yingying Yu, Manfred Schartl, Deborah Mary Power, Chen Li, Wenxiu Ma, Yanxu Sun, Shuo Li, Bowen Yue, Weijing Li & Changwei Shao. (2023) Exosome delivery to the testes for dmrt1 suppression: A powerful tool for sex-determining gene studies. Journal of Controlled Release 363, pages 275-289.
Crossref
Barbara Anne Fraser, Alexandra Louise Wilkins, Geoffry Nunzio De Iuliis, Diane Rebourcet, Brett Nixon & Robert John Aitken. (2023) Development of a model for studying the developmental consequences of oxidative sperm DNA damage by targeting redox-cycling naphthoquinones to the Sertoli cell population. Free Radical Biology and Medicine 206, pages 50-62.
Crossref
Hongyan Liu, Xialin Zhu, Yuyan Wei, Chunhong Song & Yunshan Wang. (2023) Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems. Biomedicine & Pharmacotherapy 157, pages 114065.
Crossref
Jingjing Xiao, Yingying Lu, Lu Deng, Wulian Chen, Weiguo Hu, Yuqing Zhao & Shouzhen Chen. (2022) Co‐delivery of paclitaxel and CXCL1 shRNA via cationic polymeric micelles for synergistic therapy against ovarian cancer . Polymer International 71:10, pages 1220-1229.
Crossref
Ting Wang, Yunhong Yao, Xinrong Hu & Yi Zhao. (2022) Message in hand: the application of CRISPRi, RNAi, and LncRNA in adenocarcinoma. Medical Oncology 39:10.
Crossref
Tao Li, Yue Li, Hina Rehmani, Jianhui Guo, Ravi Padia, Ozlem Calbay, Zuo Ding, Yunhan Jiang, Lingtao Jin & Shuang Huang. (2022) Attenuated miR-203b-3p is critical for ovarian cancer progression and aptamer/miR-203b-3p chimera can be explored as a therapeutic. Advances in Cancer Biology - Metastasis 4, pages 100031.
Crossref
Yingshu Guo, Xiuping Cao, Xiaofei Zheng, Sk Jahir Abbas, Juan Li & Weihong Tan. (2022) Construction of nanocarriers based on nucleic acids and their applications in nanobiology delivery systems. National Science Review 9:5.
Crossref
Barbara Fraser, Alexandra E. Peters, Jessie M. Sutherland, Mingtao Liang, Diane Rebourcet, Brett Nixon & Robert J. Aitken. (2021) Biocompatible Nanomaterials as an Emerging Technology in Reproductive Health; a Focus on the Male. Frontiers in Physiology 12.
Crossref
Zhe Wang, Fenghua Meng & Zhiyuan Zhong. (2021) Emerging targeted drug delivery strategies toward ovarian cancer. Advanced Drug Delivery Reviews 178, pages 113969.
Crossref
Nunzianna Doti, Mario Mardirossian, Annamaria Sandomenico, Menotti Ruvo & Andrea Caporale. (2021) Recent Applications of Retro-Inverso Peptides. International Journal of Molecular Sciences 22:16, pages 8677.
Crossref
Amal A. Al-Dossary, Essam A. Tawfik, Adaugo C. Isichei, Xin Sun, Jiahe Li, Abdullah A. Alshehri, Munther Alomari, Fahad A. Almughem, Ahmad M. Aldossary, Hussein Sabit & Abdulaziz M. Almalik. (2021) Engineered EV-Mimetic Nanoparticles as Therapeutic Delivery Vehicles for High-Grade Serous Ovarian Cancer. Cancers 13:12, pages 3075.
Crossref
Neha Mehrotra, Surender Kharbanda & Harpal Singh. (2020) Peptide-based combination nanoformulations for cancer therapy. Nanomedicine 15:22, pages 2201-2217.
Crossref
Rituparna Acharya. (2019) The recent progresses in shRNA-nanoparticle conjugate as a therapeutic approach. Materials Science and Engineering: C 104, pages 109928.
Crossref
Rossella Farra, Matea Maruna, Francesca Perrone, Mario Grassi, Fabio Benedetti, Marianna Maddaloni, Maguie El Boustani, Salvo Parisi, Flavio Rizzolio, Giancarlo Forte, Fabrizio Zanconati, Maja Cemazar, Urska Kamensek, Barbara Dapas & Gabriele Grassi. (2019) Strategies for Delivery of siRNAs to Ovarian Cancer Cells. Pharmaceutics 11:10, pages 547.
Crossref
Lin Tang, Pin Wang, Qilin Wang & Lan Zhong. (2019) Correlation of LAMA3 with onset and prognosis of ovarian cancer. Oncology Letters.
Crossref
Zhiquan Liang, Ziwen Lu, Yafei Zhang, Dongsheng Shang, Ruyan Li, Lanlan Liu, Zhicong Zhao, Peishan Zhang, Qiong Lin, Chunlai Feng, Yibang Zhang, Peng Liu, Zhigang Tu & Hanqing Liu. (2019) Targeting Membrane Receptors of Ovarian Cancer Cells for Therapy. Current Cancer Drug Targets 19:6, pages 449-467.
Crossref
Olga Kutova, Evgenii Guryev, Evgeniya Sokolova, Razan Alzeibak & Irina Balalaeva. (2019) Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency. Cancers 11:1, pages 68.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.